Kalamazoo, MI, USA / WKZO | Everything Kalamazoo | 590 AM · 106.9 FM
Feb 4, 2021 6:38 AM
KUALA LUMPUR (Reuters) - Malaysia s Solution Group Bhd said on Thursday it has signed a term sheet agreement with the government to supply 3.5 million doses of COVID-19 vaccine jointly developed by China s CanSino Biologics Inc and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences.
The company, whose website shows it is an engineering as well as biopharmaceuticals business, said in a bourse filing that its wholly-owned unit Solution Biologics had signed the agreement on Jan. 29 with the Health Ministry.
The agreement will enable the subsidiary to enter into a definitive supply agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine for the prevention of COVID-19, it said.